Heier Jeffrey S.
Ocular Therapeutix, Inc. · Chief Scientific Officer
Heier Jeffrey S. is listed in filings as Chief Scientific Officer at Ocular Therapeutix, Inc.. This profile follows SEC Form 4 activity through May 28, 2026, including sale activity. Recent filings connect the profile to Ocular Therapeutix, Inc. (OCUL). The current snapshot covers public activity from Oct 4, 2024 to May 28, 2026. Reported amounts are shown as $24.7K to $2.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $25k3.1k shares | SellFeb 23, 2026 | $8.28 | $9.17 | |
| $42k3.5k shares | SellNov 24, 2025 | $12.04 | $9.17 | |
| $116k10.5k shares | SellOct 2, 2025 | $11.04 | $9.17 | |
| $37k3.1k shares | SellAug 25, 2025 | $12.04 | $9.17 | |
| $22k3k shares | SellMay 23, 2025 | $7.18 | $9.17 | |
| $21k3.1k shares | SellFeb 24, 2025 | $6.87 | $9.17 | |
| $27k2.9k shares | SellNov 25, 2024 | $9.01 | $9.17 |